An urgent plea: Give the use of prolonged propofol infusion a second thought

Intensive Care Medicine

Volumn 39, Issue 11, 2013, Pages 2058-2059

  Van De Voorde, Patrick ^a   Van Lander, Arnaud ^a   Colpaert, Kirsten ^a   Verrijckt, Ann ^a   Dhont, Evelyn ^a   De Jaeger, Annick ^a  

^a UH Ghent Department of Respiratory Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

HUMAN; INTENSIVE CARE; LETTER; PROPOFOL INFUSION SYNDROME; RISK FACTOR; SEDATION; SYMPTOMATOLOGY;

ADOLESCENT; ANESTHETICS, INTRAVENOUS; HUMANS; INFUSIONS, INTRAVENOUS; PROPOFOL; RISK FACTORS;

EID: 84885422328     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3058-x     Document Type: Letter

References (5)

1. Fudickar A, Bein B (2009) Propofol infusion syndrome: Update of clinical manifestation and pathophysiology. Minerva Anestesiol 75:339-344
2. Kruessell MA, Udink ten Cate FE, Kraus AJ, Roth B, Trieschmann U (2012) Use of propofol in pediatric intensive care units: A national survey in Germany. Pediatr Crit Care Med 13(3):e150-e154
3. Vet NJ, Ista E, De Wildt SN, Van Dijk M, Tibboel D, De Hoog M (2013) Optimal sedation in pediatric intensive care patients: A systematic review. Intensive Care Med. doi: 10;1007/s00134-013-2971-3
4. Roberts RJ, Barletta JF, Fong JJ et al (2009) Incidence of propofol-related infusion syndrome in critically ill adults: A prospective, multicenter study. Crit Care 13(5):R169
5. Veldhoen ES, Hartman BJ, van Gestel JP (2009) Monitoring biochemical parameters as an early sign of propofol infusion syndrome: False feeling of security. Pediatr Crit Care Med 10:e19-e21